New Stanford list of HIV mutations vital to tracking AIDS epidemic

March 06, 2009

STANFORD, Calif. - In a collaborative study with the World Health Organization and seven other laboratories, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends throughout the world.

The researchers analyzed data from about 15,220 patients across the globe to develop an updated and accurate list of the most common, resistance-related mutations of the virus. The list will be published March 6 in the online journal PLoS-One.

"The epidemic is changing, especially as new drugs are being developed," said Robert Shafer, MD, associate professor of infectious diseases and geographic medicine at Stanford and the senior author of the paper. "To effectively track the spread of drug resistance, particularly transmitted drug resistance, you need a sensitive and specific list that's considered standard and is adopted by all the surveillance studies."

The list is important, he said, as it helps countries gauge the effectiveness of their HIV medication programs. But assembling such a list can be a challenge, particularly with a virus that has so many resistance-related variants. On the one hand, if the list is too liberally defined, then HIV drug funders and providers may believe resistance is more widespread than is actually the case.

"That will cause problems in countries. They may be concerned about whether their drugs will work," Shafer said.

On the other hand, if the list is too restrictive, there is a risk of underestimating the actual extent of resistance, he said.

"So there is a real challenge to using the right number of mutations," Shafer said.

In 2007, Shafer and his colleagues published a similar list of 80 HIV mutations that has since served as the basis for global AIDS surveillance work. However, with the scale-up of antiretroviral drug programs in the last two years and the introduction of new medications, resistance patterns have changed. So there was a need for a newly updated reference, he said.

The data used in the study was derived from a publicly available, searchable database that Shafer and his colleagues began at Stanford in 1998. Known as the Stanford HIV RT and Protease Sequence Database, it includes information on the two key proteins targeted by HIV drugs: reverse transcriptase and protease. More recently, the researchers have begun gathering resistance data on integrase inhibitors, the latest class of antiretroviral drugs to be introduced. However, this data was not included in the study, as these drugs are not yet in wide use, particularly in developing countries.

To compile the latest list, the researchers added data from other laboratories in Europe, Canada and the United States to include more than 15,000 sequences from untreated individuals, double the number available in 2007. To ensure geographic diversity, information was included for eight different subtypes of the virus, as these vary from one region of the world to another.

The researchers scoured the data to ensure they included only those mutations that were clearly recognized as causing or contributing to resistance. They excluded polymorphisms, or variants of the virus that can arise naturally, as well as drug-related mutations that occur rarely.

The result was that 16 new mutations were added to the 2007 list, while three were dropped. Shafer said it was reassuring to find minimal changes were needed.

"It shows the first list was quite good," he said.

Shafer's Stanford colleagues in the study are Mark Kiuchi, Tommy Liu, Soo-Yon Rhee and Jonathan Schapiro, MD. The research was funded by the National Institutes of Health.

The Stanford database can be found at: http://hivdb.stanford.edu.

Stanford University Medical Center

---

---

	Once-daily regimens are no match for HIV: mutations provide escape routes.(Clinical Rounds): An article from: Family Practice News by Sherry Boschert (Author) This digital document is an article from Family Practice News, published by International Medical News Group on May 1, 2004. The length of the article is 953 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Once-daily regimens are no match for HIV: mutations provide escape routes.(Clinical Rounds) Author: Sherry Boschert Publication: Family Practice News (Magazine/Journal) Date: May 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 9 Page: 24(2) Distributed by Thomson...
	HAART interruptions increase odds of HIV treatment failure and mutations.(Infectious Diseases): An article from: Internal Medicine News by Sherry Boschert (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on June 15, 2004. The length of the article is 392 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: HAART interruptions increase odds of HIV treatment failure and mutations.(Infectious Diseases) Author: Sherry Boschert Publication: Internal Medicine News (Magazine/Journal) Date: June 15, 2004 Publisher: International Medical News Group Volume: 37 Issue: 12 Page: 57(1) Distributed by Thomson...
	HIV/AIDS: A Very Short Introduction (Very Short Introductions) by Alan Whiteside (Author) HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means...
	The Mutation by Howard D. Beardmore (Author) You now live in the era of the superbugs—bacteria and viruses that either have found their way around existing drugs designed to control them or have been smart enough to outfox the best medical science has had to offer. Herpes, both oral and genital—the latter for a while creating a legion of “untouchables”—and now HIV proliferates at a frightening rate in many of the countries of the world. In the United States, thanks to an act of Congress, HIV carriers are protected by law, so they are free to spread, unmolested, their fatal disease to me and to you!
	Genotype test: should you or shouldn't you?(Bottom Lines)(Brief Article): An article from: HIV Treatment: ALERTS! by The Center for AIDS: Hope & Remembrance Project (Publisher) This digital document is an article from HIV Treatment: ALERTS!, published by The Center for AIDS: Hope & Remembrance Project on October 1, 2004. The length of the article is 681 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Genotype test: should you or shouldn't you?(Bottom Lines)(Brief Article) Publication: HIV Treatment: ALERTS! (Newsletter) Date: October 1, 2004 Publisher: The Center for AIDS: Hope & Remembrance Project Page: 11(1) Article Type: Brief Article Distributed by Thomson...
	Science Sold Out: Does HIV Really Cause AIDS? by Rebecca Culshaw (Author), Harvey Bialy (Foreword) There are many well-established scientific reasons that the HIV/AIDS hypothesis is highly doubtful. In Science Sold Out, Rebecca Culshaw describes her slow uncovering of these reasons over her years researching HIV for her work constructing mathematical models of its interaction with the immune system. It is rare that a researcher who has received funding to study HIV ever expresses any doubt in the paradigm, and an even rarer event still when she abandons the field altogether. This book focuses on the changing definition of AIDS and the flaws in all HIV testing. In a much broader sense, it explains how the current, government-based structure of scientific research has corrupted science as the search for truth. It offers not only scientific reasons for HIV/AIDS being untenable, but also...
	Adult Human Brains Add New Cells / Cancer Drug Helps Paralyzed Mice Walk / Studies Support an Accelerating Universe / Time Proves Not Reversible at Deepest Level / Blood, Semen Harbor Distinct HIV Mutations (Science News, Volume 154, Number 18, October 31, 1998) by Julie Ann Miller (Editor)
	Immunology and the Quest for an HIV Vaccine: A New Perspective by Dr. Omar Bagasra (Author) How many human immune systems are there? How old are they? Why is there no AIDS vaccine? Is a new approach needed? Why is public opinion growing skeptical of the scientific community after three decades of public awareness about HIV/AIDS? Consider answers to these puzzling questions. Learn from the decades of experience of two senior scholars: Dr. Omar Bagasra (an eminent molecular biologist, immunologist, and retrovirologist) and Dr. Donald Gene Pace (a highly published writer who examines public health policy). Explore intriguing new possibilities about human immunity, and the development of an effective AIDS vaccine. Read Immunology and the Quest for an HIV Vaccine. Benefit from an informed synthesis backed by a wealth of peer-reviewed scientific references. Review basic concepts of...
	Application of Causal Inference Methods to Improve Treatment of HIV Infection by Maya Petersen (Author) Advances in causal inference have improved the ability of statistical methods to answer practical questions in epidemiology and clinical research. In particular, the counterfactual framework and marginal structural models have provided the basis for practical and theoretical advances in the statistical estimation of causal parameters. The dissertation focuses on the development and application of statistical methods based on the counterfactual framework. Three methods are presented and each is applied to answer a practical research question. The presentation of each method is aimed at a distinct audience: clinicians, epidemiologists, and statisticians, respectively. The unifying theme is the use of state-of-the-art causal inference methods to answer questions surrounding the treatment of...
	HIV Protocols: Second Edition (Methods in Molecular Biology) by Vinayaka R. Prasad (Editor), Ganjam V. Kalpana (Editor) Despite major advances in HIV treatment, many areas require more study, in order to create efficacious, potent antiretrovirals that can suppress viral load completely and durably without toxic side effects, to define unknown drug targets and fine-tune known targets, and to better understand the interplay between viral and host factors. In "HIV Protocols, Second Edition", expert researchers provide clear, state-of-the-art methods for the study of HIV. Directed toward three specific goals, this text aims to document up-to-date protocols for select aspects of HIV biology, to bring together both virological and immunological approaches in a single, convenient volume, and to present a comprehensive account of a range of techniques not available in any existing HIV protocol book. As a volume in...